(0.05%) 5 476.20 points
(0.08%) 38 811 points
(-0.03%) 17 852 points
(0.27%) $80.55
(0.65%) $2.81
(0.14%) $2 332.20
(-0.26%) $29.32
(-0.05%) $970.40
(0.01%) $0.932
(-0.17%) $10.64
(0.05%) $0.788
(-1.86%) $86.80
Live Chart Being Loaded With Signals
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 37 419 |
Vidutinė apimtis | 2.74M |
Rinkos kapitalizacija | 2.43B |
EPS | $0.0778 ( Q1 | 2024-05-09 ) |
Kita pelno data | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-523.25 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0120 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-14 | Grossman Adam S | Sell | 460 000 | Common Stock |
2024-06-14 | Grossman Adam S | Sell | 10 000 | Common Stock |
2024-06-14 | Grossman Adam S | Sell | 100 000 | Common Stock |
2024-04-01 | Kestenberg-messina Kaitlin M. | Buy | 192 320 | Common Stock |
2024-04-01 | Kestenberg-messina Kaitlin M. | Buy | 300 328 | Stock Option (right to buy) |
INSIDER POWER |
---|
-21.33 |
Last 100 transactions |
Buy: 7 211 788 | Sell: 10 422 560 |
Tūris Koreliacija
ADMA Biologics Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
OZEM | 1 |
EM | 0.951 |
WWD | 0.945 |
IESC | 0.939 |
APOG | 0.939 |
USLM | 0.937 |
NATL | 0.937 |
JDZG | 0.934 |
AEYE | 0.932 |
SFM | 0.928 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
HSDT | -0.947 |
MRAM | -0.936 |
FRSH | -0.928 |
SPT | -0.925 |
CVRX | -0.916 |
NAAS | -0.914 |
OTEX | -0.913 |
FTRE | -0.912 |
BON | -0.909 |
LINK | -0.908 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
ADMA Biologics Inc Koreliacija - Valiuta/Žaliavos
ADMA Biologics Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $258.21M |
Bruto pelnas: | $88.22M (34.16 %) |
EPS: | $-0.130 |
FY | 2023 |
Pajamos: | $258.21M |
Bruto pelnas: | $88.22M (34.16 %) |
EPS: | $-0.130 |
FY | 2022 |
Pajamos: | $154.08M |
Bruto pelnas: | $35.27M (22.89 %) |
EPS: | $-0.430 |
FY | 2021 |
Pajamos: | $80.94M |
Bruto pelnas: | $1.17M (1.45 %) |
EPS: | $-0.832 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.